Associated Papers
Targeting the EGF receptor family in non-small cell lung cancer-increased complexity and future perspectives.
Boch T et al.
Cancer Biology & Medicine, 2022
Aumolertinib-based comprehensive treatment for an uncommon site of EGFR exon 20 insertion mutations with multiple metastases non-small cell lung cancer: a case report.
Deng Y et al.
Anti-cancer Drugs, 2022
Select a paper to view details